VCMCVC Market Cap
Menu

Funding round

Cerevel Growth

Reported as "Growth Equity"

Cerevel, which works in pharmaceutical research and development in Cambridge, raised $125M in a Growth round announced on 13 Apr 2021. 2 firms took part. It is Cerevel's third venture round on record; the one before was a Growth in Oct 2020.

$125M

Amount raised

of which $125M debt

Not disclosed

Post-money valuation

2

Investors

no lead named

Valuation

What this round says about the price

Cerevel did not disclose a valuation in this round. It came 6 months after Cerevel's Growth. It is 14% of the $915M Cerevel has raised in the venture rounds on record. No later venture round is on record for Cerevel.

Cerevel's funding rounds

Cerevel has 3 venture rounds on record and 1 other deal. This one is highlighted.

  1. Growth 23 Oct 2018, led by Bain Capital Private Equity $350M
  2. Growth 27 Oct 2020, led by Perceptive Advisors $440M
  3. Growth this round 13 Apr 2021 $125M
  4. Debt not a venture round 12 Aug 2022 $300M

Investors

Who put money in

2 firms took part; no lead investor was named.

Investors

  • backs 6 venture-backed companies new investor
  • backs 70 venture-backed companies new investor

Use of proceeds

What the money is for

According to the announcement, the money goes to product development.

  • Product development

Comparable rounds

How it compares

23 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $60M, and this round was 2.1 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:

Growth rounds in Pharmaceutical Products, Apr 2020 to Apr 2022: 23 rounds with an amount, log scale.
Comparable rounds
CompanyAnnouncedAmountPost-moneyLed by
Pharmaceutical Products12 Apr 2021$100Mnot disclosednot named
Pharmaceutical Products26 Apr 2021$30Mnot disclosedBaird Capital
Amoun Pharmaceutical Pharmaceutical Products31 Mar 2021$740Mnot disclosednot named
Pharmaceutical Products20 May 2021$30Mnot disclosednot named
Pharmaceutical Products17 Feb 2021$77Mnot disclosednot named
Pharmaceutical Products22 Jun 2021$42Mnot disclosedUCB Ventures and The Column Group
Pharmaceutical Products19 Feb 2021$35Mnot disclosednot named
Pharmaceutical Products16 Jun 2021$32Mnot disclosedDSM Venturing

Sources

Where this comes from

Reported by 6 sources.

Questions

Frequently asked

How much did Cerevel raise in its Growth round?

Cerevel raised $125M in its Growth round, announced in Apr 2021.

Which investors took part in Cerevel's Growth round?

NovaQuest Capital Management and Bain Capital.

What was Cerevel's valuation at the Growth round?

It was not disclosed.

How does it compare with other Growth rounds in Pharmaceutical Products?

23 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $60M, and this round was 2.1 times the median.